Suzuki K, Kono N, Onishi T, Tarui S
Second Department of Internal Medicine, Osaka University Medical School, Japan.
Acta Endocrinol (Copenh). 1987 Oct;116(2):282-6. doi: 10.1530/acta.0.1160282.
The effect of hypermagnesaemia on serum levels of immunoreactive calcitonin was studied in normal human subjects. After iv administration of magnesium sulphate over 120 min, the mean (+/- SEM) serum magnesium concentration rose from the baseline level of 0.9 +/- 0.1 to 2.6 +/- 0.3 mmol/l (P less than 0.01), and thereafter remained higher than the baseline level. The magnesium infusion caused a significant increase in serum immunoreactive calcitonin levels (P less than 0.01). The rise in serum magnesium concentration was accompanied by a significant decrease in the concentrations of corrected serum calcium and whole blood ionized calcium (P less than 0.01, P less than 0.01 respectively). Our results suggest that hypermagnesaemia causes an increase in serum immunoreactive calcitonin levels in normal human subjects despite a decrease in the concentrations of corrected serum calcium and whole blood ionized calcium.
在正常人体受试者中研究了高镁血症对血清免疫反应性降钙素水平的影响。静脉注射硫酸镁120分钟后,血清镁平均浓度(±标准误)从基线水平0.9±0.1mmol/L升至2.6±0.3mmol/L(P<0.01),此后一直高于基线水平。输注镁导致血清免疫反应性降钙素水平显著升高(P<0.01)。血清镁浓度升高的同时,校正血清钙和全血离子钙浓度显著降低(分别为P<0.01,P<0.01)。我们的结果表明,在正常人体受试者中,尽管校正血清钙和全血离子钙浓度降低,但高镁血症仍会导致血清免疫反应性降钙素水平升高。